article The Role Of Fucosylated And Sialylated Human Milk Oligosaccharides In Infant Nutrition 6 October 2020 | By Clifford A Adams, Jennewein Biotechnologie Human milk oligosaccharides are the third most abundant component of human milk after lactose and lipids, reaching between 5 and 20 g/L in mature human milk.
article A way to combat norovirus? 14 August 2020 | By Dr Katja Parschat Dr Katja Parschat explains how biotechnology-derived complex oligosaccharides inhibit the binding of norovirus to its natural receptors.
article Can human milk oligosaccharides modulate autoimmune diseases? 9 July 2020 | By Bettina Gutiérrez, Clifford Adams, Jennewein Biotechnologie The pathogenesis of autoimmune diseases is not completely understood, but environmental factors such as life-style, diet, drugs, and infections are thought to be involved.
article Human milk oligosaccharides during pregnancy 8 June 2020 | By Bettina Gutiérrez (Jennewein Biotechnologie) Dr. Evelyn Jantscher-Krenn is a well-known researcher and specialist in the field of human milk oligosaccharides, glycobiology, pregnancy and placenta.
news Human milk oligosaccharides, a success story 28 April 2020 | By Bettina Gutiérrez (Jennewein Biotechnologie), Jennewein Biotechnologie Jennewein Biotechnolgie produces human milk oligosaccharides (HMOs), which are functional sugars.
article Artificial HMOs mimic mothers’ secret formula 18 November 2019 | By Claudia M Hüther-Franken (on behalf of Jennewein Biotechnologie), Jennewein Biotechnologie HMO’s are special sugars that play a crucial role in baby’s development. With biotechnological processes they can be produced on industrial scale.
article Breast milk sugars can protect babies from deadly diarrhoea 28 June 2019 | By Andy Extance Jennewein Biotechnologie discusses the importance of adding human milk oligosaccharides (HMOs) to infant formula to better emulate the benefits of breast milk.
news Jennewein Biotechnologie and Yili Group join forces in China 26 June 2019 | By Jennewein Biotechnologie Jennewein Biotechnologie and Yili Group join forces for microbiome research and human milk oligosaccharides to bring innovation to the largest baby food market.
article Dairy – In-Depth Focus 2019 20 June 2019 | By New Food Our Dairy In-Depth Focus features Dr Maryanne Drake of North Carolina State University as she explores reducing sugar techniques in products such as ice cream, yoghurt, and flavoured milk.
article Sugars from human milk – a secret weapon against allergies? 24 April 2019 | By Claudia M Hüther-Franken (on behalf of Jennewein Biotechnologie) Jennewein Biotechnologie discusses the importance of human milk oligosaccharides (HMOs) in reducing the likelihood of children developing allergies.
whitepaper Gut bacteria influences our health from birth onwards 20 February 2019 | By Jennewein Biotechnologie How the microbiome develops during childhood has repercussions for the rest of our lives. It influences our risk of developing allergies, intestinal illnesses and becoming overweight. Nutrition plays an important role from the outset. Polysaccharides in breast milk – human milk oligosaccharides (HMO) – can promote a healthy intestinal flora.
